Advisory Services Network, LLC Alaunos Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$1.44 - $2.73 $233 - $442	-162 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $426 - $594	162 New	162 $0
Q1 2021 May 24, 2021	SELL	$2.82 - $5.6 $456 - $907	-162 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $387 - $555	162 New	162 $0
Q2 2020 Aug 10, 2020	SELL	$2.2 - $3.71 $356 - $601	-162 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$4.0 - $6.54 $4,000 - $6,540	-1,000 Reduced 86.06%	162 $1,000
Q3 2017 Oct 12, 2017	BUY	$4.99 - $6.57 $4,990 - $6,570	1,000 Added 617.28%	1,162 $7,000
Q2 2017 Aug 17, 2017	BUY	N/A	162	162 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $368M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.